Literature DB >> 19950297

Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis.

Christian Stehlik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19950297      PMCID： PMC2835694          DOI： 10.1002/art.24961

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  48 in total

1.  Rapid responses to anakinra in patients with refractory adult-onset Still's disease.

Authors:  Avril A Fitzgerald; Sharon A Leclercq; Alexander Yan; Joanne E Homik; Charles A Dinarello
Journal:  Arthritis Rheum       Date:  2005-06

2.  Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells.

Authors:  S Sugawara; A Uehara; T Nochi; T Yamaguchi; H Ueda; A Sugiyama; K Hanzawa; K Kumagai; H Okamura; H Takada
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

3.  Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells.

Authors:  Shinobu Saijo; Masahide Asano; Reiko Horai; Hiroaki Yamamoto; Yoichiro Iwakura
Journal:  Arthritis Rheum       Date:  2002-02

4.  Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

Authors:  I K Campbell; K O'Donnell; K E Lawlor; I P Wicks
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  NALP1 in vitiligo-associated multiple autoimmune disease.

Authors:  Ying Jin; Christina M Mailloux; Katherine Gowan; Sheri L Riccardi; Greggory LaBerge; Dorothy C Bennett; Pamela R Fain; Richard A Spritz
Journal:  N Engl J Med       Date:  2007-03-22       Impact factor: 91.245

6.  Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis.

Authors:  B T Wipke; P M Allen
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 7.  Arguments for interleukin 1 as a target in chronic arthritis.

Authors:  W B van den Berg
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

8.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

9.  Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene.

Authors:  M J Nicklin; D E Hughes; J L Barton; J M Ure; G W Duff
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

10.  Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.

Authors:  R Horai; S Saijo; H Tanioka; S Nakae; K Sudo; A Okahara; T Ikuse; M Asano; Y Iwakura
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307
View more
  21 in total

1.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

Review 2.  The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.

Authors:  P Menu; J E Vince
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

Review 3.  Innate and adaptive immune responses to cell death.

Authors:  Kenneth L Rock; Jiann-Jyh Lai; Hajime Kono
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 4.  Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.

Authors:  Massimo Cugno; Roberta Gualtierotti; Pier Luigi Meroni; Angelo Valerio Marzano
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 5.  Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

6.  SG-HQ2 inhibits mast cell-mediated allergic inflammation through suppression of histamine release and pro-inflammatory cytokines.

Authors:  In-Gyu Je; Hui-Hun Kim; Pil-Hoon Park; Taeg Kyu Kwon; Seung-Yong Seo; Tae-Yong Shin; Sang-Hyun Kim
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-27

7.  Cutting edge: IL-1β processing during Pseudomonas aeruginosa infection is mediated by neutrophil serine proteases and is independent of NLRC4 and caspase-1.

Authors:  Mausita Karmakar; Yan Sun; Amy G Hise; Arne Rietsch; Eric Pearlman
Journal:  J Immunol       Date:  2012-09-28       Impact factor: 5.422

8.  Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling.

Authors:  Christina Antonopoulos; Hana M Russo; Caroline El Sanadi; Bradley N Martin; Xiaoxia Li; William J Kaiser; Edward S Mocarski; George R Dubyak
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

9.  Inflammasome-independent IL-1β mediates autoinflammatory disease in Pstpip2-deficient mice.

Authors:  Suzanne L Cassel; John R Janczy; Xinyu Bing; Shruti P Wilson; Alicia K Olivier; Jesse E Otero; Yoichiro Iwakura; Dmitry M Shayakhmetov; Alexander G Bassuk; Yousef Abu-Amer; Kim A Brogden; Trudy L Burns; Fayyaz S Sutterwala; Polly J Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

10.  3-Hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin)-induced 28-kDa interleukin-1β interferes with mature IL-1β signaling.

Authors:  Facundo Davaro; Sorcha D Forde; Mark Garfield; Zhaozhao Jiang; Kristen Halmen; Nelsy Depaula Tamburro; Evelyn Kurt-Jones; Katherine A Fitzgerald; Douglas T Golenbock; Donghai Wang
Journal:  J Biol Chem       Date:  2014-04-30       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.